4-[3-(4-Methylphenyl)-5-oxo-4-propyl-2-thioxoimidazolidin-1-yl]-2-trifluoromethylbenzonitrile

ID: ALA1086578

PubChem CID: 46889900

Max Phase: Preclinical

Molecular Formula: C21H18F3N3OS

Molecular Weight: 417.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCC1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C)cc1

Standard InChI:  InChI=1S/C21H18F3N3OS/c1-3-4-18-19(28)27(20(29)26(18)15-8-5-13(2)6-9-15)16-10-7-14(12-25)17(11-16)21(22,23)24/h5-11,18H,3-4H2,1-2H3

Standard InChI Key:  QXZFJKVKRATIPW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    7.0569   -2.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0557   -3.5898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7706   -4.0027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4870   -3.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4841   -2.7588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7688   -2.3497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3412   -2.3444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6266   -1.9320    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3409   -4.0018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6268   -3.5887    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.3403   -4.8268    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.1281   -3.2047    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.1547   -4.0664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1620   -4.8913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9488   -5.1393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4279   -4.4676    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9370   -3.8046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4989   -5.3821    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1849   -3.0177    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.2518   -4.4586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6717   -5.1710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4967   -5.1626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9028   -4.4425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4778   -3.7294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6542   -3.7413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7277   -4.4326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2107   -5.9217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6641   -6.5396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9259   -7.3220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  8  3  0
  1  7  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
  4 13  1  0
 14 18  2  0
  2  9  1  0
 17 19  2  0
 16 20  1  0
  4  5  1  0
  9 10  1  0
 20 21  2  0
  2  3  1  0
 21 22  1  0
  9 11  1  0
 22 23  2  0
  5  6  2  0
 23 24  1  0
  9 12  1  0
 24 25  2  0
 25 20  1  0
 13 14  1  0
 23 26  1  0
  6  1  1  0
 15 27  1  0
  1  2  2  0
 27 28  1  0
  3  4  2  0
 28 29  1  0
M  END

Associated Targets(non-human)

Ar Androgen Receptor (5522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.46Molecular Weight (Monoisotopic): 417.1123AlogP: 5.19#Rotatable Bonds: 4
Polar Surface Area: 47.34Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.95CX Basic pKa: CX LogP: 5.99CX LogD: 5.99
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.64Np Likeness Score: -1.33

References

1. Jung ME, Ouk S, Yoo D, Sawyers CL, Chen C, Tran C, Wongvipat J..  (2010)  Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC).,  53  (7): [PMID:20218717] [10.1021/jm901488g]

Source